You searched for "Lucentis"
Lucentis for pseudophakic CMO
1 October 2015
| Saruban Pasu
|
Retina / Uvea / Vitreous
|
Cataract, Irvine-Gass syndrome, cystoid macular edema, phacoemulsification, ranibizumab
Pseudophakic cystoid macular oedema (CMO) develops angiographically in up to 20-30% after uneventful phacoemulsification. This study aimed to evaluate the potential efficacy and safety of intravitreal ranibizumab in patients with pseudophakic CMO after cataract surgery. Seven eyes were included in...
RPE tears after intravitreal Lucentis
1 February 2017
| Saruban Pasu
|
Retina / Uvea / Vitreous
The current hypothesis regarding retinal pigment epithelium (RPE) tears is the contraction and fibrosis in choroidal neovascularisation (CNV) tissue after anti-VEGF therapy can induce rips in the overlying RPE. This South Korean study aimed to identify the association between RPE...
What's trending Dec/Jan 2021
7 December 2020
| David Ellis
|
Ophthalmology, Optometry, Retina / Uvea / Vitreous, Cataract and Refractive
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #threeblindmice US company Nanoscope Therapeutics has developed a new treatment which is hoped will restore vision in those affected by retinal...
Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment
1 February 2015
| Rubina Rahman, Egle Rostron, Kamron Khan
|
Ophthalmology, Retina / Uvea / Vitreous
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...
Injection frequency and anatomic outcomes following conversion to Aflibercept in neovascular AMD patients
1 December 2014
| Jonathan Chan
|
Retina / Uvea / Vitreous
|
Degeneration, Macula, Treatment Medical
This is a retrospective study of patients with neovascular age-related macular degeneration (AMD) treated with intravitreal Lucentis and / or Avastin who were switched to aflibercept (Eylea). This study was carried out by the Casey Eye Institute retinal clinics, between...
Ectopia lentis management
1 April 2016
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
This review discusses the management of non-traumatic ectopia lentis in the paediatric population focussing on the variety of surgical options for these patients. The review considers visual sequelae and conservative management, limitations for surgery with respect to historical and current...
Ocular characteristics in Marfan syndrome
1 February 2014
| Nana Theodorou
|
Cataract and Refractive
|
Marfan syndrome, aphakia, axial length, cataract, ectopia lentis, flattened cornea, myopia, pseudophakia, retinal detachment
Marfan syndrome (MFS) is a genetic disorder with clinical manifestations associated with cardiovascular, ocular and skeletal organ systems. Typical signs are descending aortic root aneurysms, ectopia lentis, tall stature and scoliosis. This observational study looked at the ocular characteristics, visual...
Turn up anytime
1 April 2015
| Gwyn Samuel Williams
|
AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
When I was starting off in ophthalmology my then boss had a standard spiel after completing a cataract case. It did not vary and I do not recall an instance of it not taking place. “The operation went well and...
RPE tears in cases of IPCV
1 April 2020
| Saruban Pasu
|
Retina / Uvea / Vitreous
The aim of this study was to investigate the occurrence, characteristics, management and prognosis of retinal pigment epithelium (RPE) tears in patients with polypoidal choroidal vasculopathy (PCV). Medical records of previous cases were reviewed over an eight-year period from a...
Myopic choroidal neovascularisation
1 August 2015
| Jonathan Chan
|
Retina / Uvea / Vitreous
|
Neovascularisation, Retina, Treatment Medical
This is a review article summarising the latest myopic CNV (choroidal neovascularisation) literature in the clinical experience and management outcomes for recommendation algorithm. The aetiology of the myopic CNV was discussed by the authors under the heading of the heredo-degenerative...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
1 April 2015
| Jonathan CP Roos
|
Retina / Uvea / Vitreous
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
Managing cataract surgery in a patient with diabetic maculopathy
1 August 2016
| Fahd Quhill, Samer Elsherbiny
|
Cataract and Refractive
A 56-year-old type 2 diabetic with previously treated bilateral diabetic maculopathy develops a cataract requiring surgery in the right eye. He has had grid laser previously, followed intermittently by intravitreal triamcinalone, Avastin and more recently Lucentis in both eyes. His...